{"id":"https://openalex.org/W3203829677","doi":"https://doi.org/10.1016/j.annonc.2021.08.1208","title":"766P Mapping BRCA1/2 variants in ovarian cancer patients: Contribution of a BRCA2 founder effect","display_name":"766P Mapping BRCA1/2 variants in ovarian cancer patients: Contribution of a BRCA2 founder effect","publication_year":2021,"publication_date":"2021-09-01","ids":{"openalex":"https://openalex.org/W3203829677","doi":"https://doi.org/10.1016/j.annonc.2021.08.1208","mag":"3203829677"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2021.08.1208","doi":"https://doi.org/10.1016/j.annonc.2021.08.1208","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1208","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(21)03437-2/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.annalsofoncology.org/article/S0923-7534(21)03437-2/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103216889","display_name":"Teresa Duarte","orcid":"https://orcid.org/0009-0000-1057-1585","observed_orcids":["https://orcid.org/0009-0000-1057-1585"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"T. Duarte","raw_affiliation_strings":["Molecular Pathobiology Research Unit, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pathobiology Research Unit, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027040222","display_name":"Sofia Fragoso","orcid":"https://orcid.org/0000-0001-8102-6883","observed_orcids":["https://orcid.org/0000-0001-8102-6883"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"S. Fragoso","raw_affiliation_strings":["Molecular Pathobiology Research Unit, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pathobiology Research Unit, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016148937","display_name":"Pedro Antunes Meireles","orcid":"https://orcid.org/0000-0002-3356-1969","observed_orcids":["https://orcid.org/0000-0002-3356-1969"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"P. Antunes Meireles","raw_affiliation_strings":["Medical Oncology Dept., Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]},{"raw_affiliation_string":"Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":null,"display_name":"I.C. Oliveira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"I.C. Oliveira","raw_affiliation_strings":["Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":null,"display_name":"P. Rodrigues","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"P. Rodrigues","raw_affiliation_strings":["Medical Oncology Dept., Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]},{"raw_affiliation_string":"Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080215335","display_name":"Catarina Bexiga","orcid":"https://orcid.org/0000-0002-0554-263X","observed_orcids":["https://orcid.org/0000-0002-0554-263X"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"C. Bexiga","raw_affiliation_strings":["Medical Oncology Dept., Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]},{"raw_affiliation_string":"Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015216676","display_name":"Beatriz Mira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"B. Mira","raw_affiliation_strings":["Medical Oncology Dept., Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]},{"raw_affiliation_string":"Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111808764","display_name":"A. Opini\u00e3o","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"A. Opini\u00e3o","raw_affiliation_strings":["Medical Oncology Dept., Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]},{"raw_affiliation_string":"Medical Oncology Department, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114054991","display_name":"Ana Carla Lu\u00eds","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"A.C. Lu\u00eds","raw_affiliation_strings":["Medical Oncology Department; Cl\u00ednica de Risco Familiar, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department; Cl\u00ednica de Risco Familiar, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087466573","display_name":"I. Miguel","orcid":"https://orcid.org/0000-0002-1380-9314","observed_orcids":["https://orcid.org/0000-0002-1380-9314"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"I. Miguel","raw_affiliation_strings":["Medical Oncology Department; Cl\u00ednica de Risco Familiar, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department; Cl\u00ednica de Risco Familiar, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103260712","display_name":"S. Bento","orcid":"https://orcid.org/0000-0002-4116-4277","observed_orcids":["https://orcid.org/0000-0002-4116-4277"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"S. Bento","raw_affiliation_strings":["Cl\u00ednica de Risco Familiar, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica de Risco Familiar, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089139257","display_name":"F\u00e1tima Vaz","orcid":"https://orcid.org/0000-0002-3334-215X","observed_orcids":["https://orcid.org/0000-0002-3334-215X"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"F. Vaz","raw_affiliation_strings":["Medical Oncology Department; Cl\u00ednica de Risco Familiar, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department; Cl\u00ednica de Risco Familiar, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058789687","display_name":"Samuel D\u00e9cio Azevedo dos Santos","orcid":"https://orcid.org/0000-0002-6633-0657","observed_orcids":["https://orcid.org/0000-0002-6633-0657"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"S. Santos","raw_affiliation_strings":["Molecular Pathobiology Research Unit, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pathobiology Research Unit, Instituto Portugu\u00e8s de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), Lisbon, Portugal","institution_ids":["https://openalex.org/I4210103180"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210103180"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12962861,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":null,"first_page":"S750","last_page":"S750"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11369","display_name":"Genetic factors in colorectal cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.8809999823570251},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":1.0},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9340000152587891},{"id":"https://openalex.org/keywords/hereditary-breast-and-ovarian-cancer-syndrome","display_name":"hereditary breast and ovarian cancer","score":0.9120000004768372},{"id":"https://openalex.org/keywords/founder-mutation","display_name":"founder mutation","score":0.7149999737739563},{"id":"https://openalex.org/keywords/germline-mutations","display_name":"germline mutations","score":0.7870000004768372},{"id":"https://openalex.org/keywords/portuguese-patients","display_name":"Portuguese patients","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8610036969184875},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.8506660461425781},{"id":"https://openalex.org/C195054827","wikidata":"https://www.wikidata.org/wiki/Q504568","display_name":"Founder effect","level":5,"score":0.700832188129425},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5484715700149536},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4916568398475647},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4890535771846771},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46795356273651123},{"id":"https://openalex.org/C35219183","wikidata":"https://www.wikidata.org/wiki/Q5146","display_name":"Portuguese","level":2,"score":0.4184757471084595},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.41066187620162964},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2756490707397461},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2364118993282318},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09073930978775024},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.08154469728469849},{"id":"https://openalex.org/C197754878","wikidata":"https://www.wikidata.org/wiki/Q80711","display_name":"Haplotype","level":4,"score":0.05643683671951294},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2021.08.1208","doi":"https://doi.org/10.1016/j.annonc.2021.08.1208","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1208","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(21)03437-2/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2021.08.1208","doi":"https://doi.org/10.1016/j.annonc.2021.08.1208","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1208","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(21)03437-2/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3203829677.pdf","grobid_xml":"https://content.openalex.org/works/W3203829677.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3201919985","https://openalex.org/W4297464288","https://openalex.org/W1914960330","https://openalex.org/W2944821382","https://openalex.org/W4413141517","https://openalex.org/W3047787489","https://openalex.org/W2803644870","https://openalex.org/W3202097387","https://openalex.org/W4223513227","https://openalex.org/W2894826479"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2021-10-11T00:00:00"}